Streetbeat News

Analyst Ratings

THTX

Cantor Fitzgerald analyst Louis Chen has reiterated an Overweight rating on Theratechnologies (NASDAQ:THTX) and maintained a $9 price target.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:57 pm

ABEO

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Abeona Therapeutics (NASDAQ:ABEO) and maintained a $38 price target.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:56 pm

ICE

Barclays analyst Jeremy Campbell maintains an Equal-Weight rating on Intercontinental Exchange (NYSE:ICE) and raises the price target from $123 to $128.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:56 pm

LCID

Cantor Fitzgerald analyst Andres Sheppard has reiterated an Overweight rating on Lucid Group (NASDAQ:LCID) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:55 pm

CVNA

Carvana Co. (NYSE:CVNA) shares traded higher after JMP Securities raised its price target on the stock. The shares are up more than 250% in the last three months, sparked by better-than-expected financial results. A trader expects Carvana’s stock to trade above the $47.70 level by the end of the week.

Portfolio Pulse from Lisa Levin

July 13, 2023 | 12:54 pm

CXM

Cantor Fitzgerald analyst Brett Knoblauch has maintained an Overweight rating on Sprinklr (NYSE:CXM) and raised the price target from $17 to $20.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:53 pm

LLY

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a price target of $550.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:52 pm

ATVI

Barclays analyst Ryan Gee has downgraded Activision Blizzard (NASDAQ:ATVI) from Overweight to Equal-Weight and lowered the price target from $100 to $95.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:52 pm

ATVI

Barclays analyst Ryan Gee has downgraded Activision Blizzard (NASDAQ:ATVI) from Overweight to Equal-Weight, while raising the price target from $90 to $95.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:50 pm

CYRX

B. Riley Securities analyst Yuan Zhi has maintained a 'Buy' rating on CryoPort (NASDAQ:CYRX), but lowered the price target from $30 to $22.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 12:50 pm